MARKET

GOVX

GOVX

Geovax Labs Inc
NASDAQ
0.1579
-0.0001
-0.06%
After Hours: 0.1511 -0.0068 -4.31% 19:01 11/06 EST
OPEN
0.1580
PREV CLOSE
0.1580
HIGH
0.1582
LOW
0.1393
VOLUME
370.93K
TURNOVER
--
52 WEEK HIGH
14.35
52 WEEK LOW
0.1393
MARKET CAP
1.44M
P/E (TTM)
-0.0113
1D
5D
1M
3M
1Y
5Y
1D
GeoVax Labs, Inc. Terminates CEO David A. Dodd for Cause on November 5, 2026
NASDAQ · 5h ago
GeoVax Labs announces termination of CEO David Dodd
TipRanks · 5h ago
Stocks to Watch: Repligen, Hawaiian Electric, GeoVax Labs
Dow Jones · 6h ago
GeoVax Labs Fires CEO, Citing Refusal to Cooperate With Board
Dow Jones · 6h ago
*GeoVax: Board Determined to Treat Terrmination as a Termination for Cause, Citing Dodd's 'Refusal to Comply With Board-Approved Directives'
Dow Jones · 7h ago
*GeoVax Terminates CEO David A. Dodd
Dow Jones · 7h ago
GeoVax Labs Terminates CEO David Dodd for Cause
TipRanks · 7h ago
GeoVax Labs Terminates CEO David Dodd For Cause; Dodd Remains Board Chairman and Director
Benzinga · 8h ago
More
About GOVX
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. Its lead clinical program is GEO-CM04S1, a COVID-19 vaccine, which is in three phase II clinical trials, being evaluated as a primary vaccine for immunocompromised patients, such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient; a booster vaccine in patients with chronic lymphocytic leukemia (CLL); and a COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology, the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin, having completed a multicenter Phase I/II clinical trial for advanced head and neck cancers. It is developing GEO-MVA, a vaccine targeting Mpox and smallpox. Its other product candidates include GEO-EM01-Z, GEO-EM01-S, GEO-MM01, GEO-ZM02 and others.

Webull offers Geovax Labs Inc stock information, including NASDAQ: GOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOVX stock methods without spending real money on the virtual paper trading platform.